Literature DB >> 20848327

Newer anticonvulsant medications in pediatric neurology.

Michael M Quach1, Abdul Mazin, James J Riviello.   

Abstract

OPINION STATEMENT: Antiepileptic drugs (AEDs) are the mainstay of treatment for recurrent seizures. Uncontrolled seizures may cause medical, developmental, and psychological disturbances. The medical practitioner should thus strive to eliminate or minimize seizures. Treatment advances in epilepsy include 1) identification of the basic mechanisms of epilepsy and action of AEDs, 2) the introduction of new AEDs, and 3) the use of neurostimulation, including vagus nerve stimulation. Treatment with AEDs involves balancing each AED's efficacy against its side effects. In some patients, effective AEDs must be discontinued because of intolerable side effects. Although all AEDs have a proven efficacy, the choice of AEDs should be based on better efficacy for individual seizure types or epilepsy syndromes. Side effects also differ from drug to drug and must be taken into account. This article focuses on studies and expert opinion consensus to guide the choice of AEDs.

Entities:  

Year:  2010        PMID: 20848327     DOI: 10.1007/s11940-010-0094-5

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  51 in total

1.  Pharmacokinetics and pharmacodynamics of topiramate.

Authors:  B F Bourgeois
Journal:  J Child Neurol       Date:  2000       Impact factor: 1.987

Review 2.  New pharmacotherapies for pediatric seizures.

Authors:  John M Pellock
Journal:  Pediatr Ann       Date:  2004-06       Impact factor: 1.132

3.  Efficacy of felbamate in the treatment of intractable pediatric epilepsy.

Authors:  Mary L Zupanc; Rhonda Roell Werner; Michael S Schwabe; Sunila E O'Connor; Charles J Marcuccilli; Kurt E Hecox; Maria S Chico; Kathy A Eggener
Journal:  Pediatr Neurol       Date:  2010-06       Impact factor: 3.372

Review 4.  Levetiracetam in pediatrics.

Authors:  Federico Vigevano
Journal:  J Child Neurol       Date:  2005-02       Impact factor: 1.987

5.  First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy.

Authors:  Gerhard Kluger; Edda Haberlandt; Gerhard Kurlemann; Jan-Peter Ernst; Uwe Runge; Felix Schneider; Christine Makowski; Rainer Boor; Thomas Bast
Journal:  Epilepsy Behav       Date:  2010-02-24       Impact factor: 2.937

Review 6.  Infantile spasms.

Authors:  Eric H Kossoff
Journal:  Neurologist       Date:  2010-03       Impact factor: 1.398

7.  Randomized trial of vigabatrin in patients with infantile spasms.

Authors:  R D Elterman; W D Shields; K A Mansfield; J Nakagawa
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

8.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

9.  Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.

Authors:  Christian Tilz; Roland Resch; Thomas Hofer; Christian Eggers
Journal:  Epilepsia       Date:  2009-08-08       Impact factor: 5.864

10.  Topiramate monotherapy in infantile spasm.

Authors:  Young-Se Kwon; Yong-Hoon Jun; Young-Jin Hong; Byong-Kwan Son
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

View more
  2 in total

Review 1.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Authors:  Kevin G Bath; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-08       Impact factor: 2.937

2.  The Impact of Antiepileptic Drugs on Thyroid Function in Children with Epilepsy: New Versus Old.

Authors:  Hatem Hamed Elshorbagy; Naglaa Fathy Barseem; Hany Abdelaziz Suliman; Eman Talaat; Ashraf Hamed AlSHOKARY; Waleed Elsayed Abdelghani; Sameh Elsayed Abdulsamea; Yehia Hamed Abdel Maksoud; Sanaa Mohammed Azab; Akram Elshafey Elsadek; Dalia Mohamed Nour El Din
Journal:  Iran J Child Neurol       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.